I would guess that MRK wants to get Ivation-TA out on the market ASAP without delays related to new modifications to get Eye surgeons familiar with the device while other, better products are in the pipeline. Are we finally losing the cypher millstone around SRDX' neck? I'll bet shorts were mainly of the 'one-trick' pony view that SRDX would suffer from declining Cypher sales while not adequately factoring in the rest of their stent opportunities and the major potential of owning both devices and polymers in the opthalmology arena. Orthopedics related device announcements could propel this puppy further and we still have other eye opportunities in the works. Meanwhile non stent, non eye business keeps growing. Corning revs should be more visible soon. Cypher belongs on page 3, not page 1 anymore. I may take profits over 60/shr but will hold the bulk of my position for the long haul.
Market Data 
Markets 
AI
